LIDOCAINE (NDC, Inc.)
Welcome to the PulseAid listing for the LIDOCAINE drug offered from NDC, Inc.. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | NDC, Inc. |
NON-PROPRIETARY NAME: | Lidocaine Hydrochloride and Epinephrine Bitartrate |
SUBSTANCE NAME: | LIDOCAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-04-10 |
END MARKETING DATE: | 0000-00-00 |
LIDOCAINE HUMAN PRESCRIPTION DRUG Details:
Item Description | LIDOCAINE from NDC, Inc. |
LABELER NAME: | NDC, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20; .01(mg/mL; mg/mL) |
START MARKETING DATE: | 2015-04-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43128-105_a2f3b9cf-b8a8-4696-ad64-4dfc56e93020 |
PRODUCT NDC: | 43128-105 |
APPLICATION NUMBER: | ANDA088390 |
Other LIDOCAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE Pharmaceutical Manufacturers / Labelers: